Pooja Swamy is a Cardiology physician. OpenAlex indexes 27 publications with 342 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6200 Sunset Dr Ste 401
South Miami, FL 331434829
Telephone
305-666-4633Provider last certified this registry record 16 Oct 2025.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20252 payments
- ABIOMEDProgram year20246 payments
- Boston Scientific CorporationProgram year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
85.9%Beta blocker20.8%Carvedilol55%Metoprolol Succinate33%Metoprolol Tartrate12%Part D<11 patientsStatin17.9%Atorvastatin Calcium81%Rosuvastatin Calcium20%Part D≥50 patients+ 11 more classes in this area
Blood & clotting
10.4%P2Y12 inhibitor8.4%Clopidogrel100%Part D≥34 patientsFactor Xa inhibitor1.9%Eliquis100%Part D<11 patientsMetabolism & gastrointestinal
3.8%SGLT2 inhibitor3.8%Jardiance56%Farxiga44%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Outcomes With Limus- vs Paclitaxel-Coated Balloons for Percutaneous Coronary Intervention
JACC: Cardiovascular Interventions
2024 - Clinical Significance of Coronary Arterial Dominance: A Review of the Literature
Journal of the American Heart Association
2024 - Use of CMR in Diagnosis of MINOCA in Patients with Rheumatic Disorders
Journal of Cardiovascular Magnetic Resonance
2024 - Dual Antiplatelet and Anticoagulation Regimens for Women Undergoing Percutaneous Coronary Intervention
Interventional Cardiology Clinics
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”